TITLE

SMI driving industry discussion points to actionable strategies

AUTHOR(S)
Orthman, Dennis P.
PUB. DATE
January 2008
SOURCE
Healthcare Purchasing News;Jan2008, Vol. 32 Issue 1, p54
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on a new tool and an electronic transaction standards-based initiative introduced by Strategic Marketplace Initiative (SMI). SMI also provided updates on ongoing projects at the SMI Member Forum in November 2007. SMI is a nonprofit consortium of executives representing healthcare providers, medical products manufacturers, pharmaceutical and supply chain distribution companies and service businesses. It enumerates features of the New Product Introduction Management Tool.
ACCESSION #
28123973

 

Related Articles

  • Target Works to Enhance, Expand. Corral, Cecile B. // Home Textiles Today;2/21/2005, Vol. 26 Issue 24, p1 

    The article reports that Target Corp. this year will push ahead with supply chain and product development enhancements, but also plans ambitious expansions in its food and pharmacy offerings. The company this year will expand the number of events it tracks under this system to 45 from 21 last...

  • From Inventory to Information. Newmark, Eric // Bio-IT World;Jul/Aug2006, Vol. 5 Issue 6, p15 

    The article reports that the operation of pharmaceutical supply chains is changed by the drug safety initiatives, technical innovation and lean practices. The direct-to-consumer (DTC) distribution has increased but has driven by the concerns over drug safety. There are three opportunities for...

  • The causes of complexity. Tierney, Stephen // Supply Chain Europe;Apr2004, Vol. 13 Issue 3, p24 

    Reveals the three main factors creating supply chain complexity at present. Pursuit of new markets as the economy becomes more and more global; Increase in the speed with which companies have to bring new products to market; Pressures to reduce supply chain costs.

  • Integrity of the pharmaceutical supply chain: Product sourcing for patient safety.  // American Journal of Health-System Pharmacy;9/15/2004, Vol. 61 Issue 18, p1889 

    Examines the impact of the secondary distribution channel on the pharmaceutical supply chain. Potential impact on patient care and increased costs caused by the difficulty and inability to source products when needed; Legal and regulatory considerations; Considerations for evaluating product...

  • Pout Gets Equity Infusion.  // WWD: Women's Wear Daily;2/6/2007, Vol. 193 Issue 28, p18 

    The article reports on the recapitalization of Pout Ltd., a London, England-based independent cosmetics brand, by private equity firm Catterton Partners. Pout's original founders, Emily Cohen, Chantal Laren and Anna Singh, will remain firmly involved in the brand's creative development, while...

  • Clear distribution policy emerges from Pfizer's merger muddle. Tierney, Stephen // Supply Chain Europe;Feb2004, Vol. 13 Issue 1, p34 

    Discusses the distribution policy adopted by pharmaceutical firm Pfizer to manage the distribution sites and carrier contracts resulting from its acquisition of other firms in Europe. Factors that determine the success of outsourcing distribution and warehousing activities; Pros and cons of...

  • MAKING MONEY OUT OF PHARMA SUPPLY CHAINS. Powell, Richard // Pharma Magazine;Jul/Aug2012, Vol. 8 Issue 4, p38 

    The article discusses the challenges involved in pharmaceutical industry. It states that the challenges include a need to increase reach to the 80 percent of the world population that are not buyers from Big Pharma, necessary to operate effectively in a highly regulated environment, lack of...

  • Improving Visibility of the Pharma Supply Chain: Best Practices and Technologies. Lennard, David J.; Matlis, Daniel A. // Pharmaceutical Technology;Aug2011 Outsourcing Resources, ps26 

    The article discusses the challenges and trends in managing global supply chains in the pharmaceutical industry. It states that Axendia has conducted research about current trends in the life-sciences global supply chain, which shows that companies need to shed the perception of supply chains...

  • Trends and Novel Approaches to Clinical Supply Outsourcing. Lamberti, Mary Jo; Costello, Mary; Getz, Kenneth // Contract Pharma;Jan/Feb2012, Vol. 14 Issue 1, p40 

    The article discusses the approaches in the packaging and distribution support of the U.S. pharmaceutical industry. It notes that biopharmaceutical companies are collaborating with service providers to provide services that collectively represent clinical supply chain management. However,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics